Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy.
A 69-year-old man was admitted for evaluation of an abnormal chest X-ray. A diagnosis of primary bronchial amyloidosis was made on the basis of the chest X-ray, CT scans and bronchial biopsy specimens. The patient was treated with low-dose long-term erythromycin therapy (600 mg/day). After four months of therapy, chest CT scans, bronchoscopic findings and bronchial biopsy specimens revealed significant improvement of inflammatory changes. Low-dose erythromycin therapy may be helpful in terms of its anti-inflammatory effects for patients with bronchial amyloidosis.
Nakahara
S
S
Department of Respiratory Medicine, National Kyusyu Medical Center, Fukuoka, Japan.
Yano
T
T
Oshita
Y
Y
Shiga
Y
Y
Koga
H
H
Takeshita
M
M
Oizumi
K
K
D000368:Aged; D000686:Amyloidosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011859:Radiography
D000900:Anti-Bacterial Agents; D004917:Erythromycin